Neurostimulation Charge Density Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional neurostimulation systems face challenges in managing tissue charge safety limits, particularly with smaller electrodes that have higher charge densities, leading to potential tissue damage due to inadequate monitoring and control of charge density per pulse, and existing systems often globally monitor charge injection, neglecting differences among electrodes of varying sizes.
Innovation Solution
A neurostimulation system with control circuitry that determines and monitors tissue charge density injection metrics based on electrode size, compares these metrics to hard stop and warning thresholds, and adjusts stimulation parameters to prevent exceeding safety limits, allowing for independent control of charge injection at each electrode to ensure safe tissue stimulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If smaller electrodes are used to improve spatial resolution and targeting precision, then stimulation precision is improved, but charge density increases leading to higher risk of tissue damage
Solution Approach 1:
The patent divides the charge monitoring function into electrode-specific segments. Each electrode has its own charge density calculations and safety limits, allowing independent monitoring rather than a single global limit. This segmentation enables precise control at each electrode site while maintaining overall system safety.
Solution Approach 2:
The patent implements local charge density monitoring and control at each electrode site. The system calculates charge density specific to each electrode's surface area and applies electrode-specific safety limits, rather than using a uniform global limit. This local quality approach allows smaller electrodes to operate at their optimal charge densities without causing tissue damage.
2Device complexity
If global charge injection monitoring is used to simplify system design, then device complexity is reduced, but safety control precision deteriorates due to inability to account for individual electrode size differences
Solution Approach 1:
The monitoring system is segmented to track charge injection at each electrode independently. The patent maintains separate charge counters and safety limit registers for each electrode, enabling precise per-electrode monitoring while using a modular architecture that keeps individual components relatively simple.
Solution Approach 2:
The system dynamically adjusts safety parameters based on electrode characteristics. Charge density limits are calculated and stored for each electrode based on its surface area, allowing the monitoring precision to adapt to each electrode's specific properties while maintaining a unified monitoring framework.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A neurostimulation system for management of stimulation safety limits. The system determines a tissue charge injection metric at each electrode, compares the metric to the hard stop charge limit, and prevents the neurostimulator from delivering stimulation energy to the tissue region in accordance based on the comparison. The hard stop limit may be user-programmable or may be automatically modified in response to detection of electrode characteristics. The system may quantitatively notify a user of a value of the injected charge injected into the tissue. The electrodes may be organized into different sets, in which case, the system may directly control tissue charge independently at each of the electrode sets. If current steering is provided, the system may displace the electrical stimulation energy along the tissue region in one direction, while preventing the charge injection value at each of the electrodes from meeting or exceeding the hard stop charge limit.